Accelerating Anticancer Agent Development and Validation Workshop

Wed 3–Fri 5 May 2017
All day

Bethesda North Marriott Hotel and Conference Center, Bethesda, Maryland,

More about this event

Aim of workshop:
Leaders in clinical and translational cancer research from academia, industry, government and the nonprofit advocacy sectors convene each spring in Bethesda, Maryland, for a unique forum designed to speed cancer treatments to patients. Our three-day, on-site interactive AAADV Workshop offers a mix of small group lectures, moderated discussions, plenary lectures and facilitated case studies of successful drug applications. Participants gain valuable insights on negotiating the spectrum of successful drug development and hone their strategic planning skills with a focus on target validation and pathway identification. The AAADV is the only workshop held in collaboration with the U.S. Food and Drug Administration designed specifically to help, participants understand and negotiate the drug development approval process so that effective cancer treatments can reach patients more quickly.

The session on 3rd May:
• Incorporating the Role of Radiotherapy in Clinical Trials of New Drugs
Moderator :
o Amanda Walker, M.D.; U.S. Food and Drug Administration
Panelists :
o Silvia Formenti, M.D.; Weill Cornell Medicine
o David Raben, M.D.; University of Colorado
o Ozlem Ataman, M.D., Ph.D.; Eisai Pharmaceuticals
o Ricky Sharma, M.D., Ph.D.; University College London

External link:
https://www.acceleratingworkshop.org/2017/

Add to calendar

Loading Map....